Related Experiment Video
Updated: Jan 7, 2026

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Redefining the Limits of Nanodevices-Based Drug Delivery Systems: Extracellular Vesicles
Marina Lucia Díaz1,2, Victoria Simón1,3, Luciano Alejandro Benedini1,4
1Departmento de Biología, Bioquímica y Farmacia, Universidad Nacional del Sur (UNS), Bahía Blanca 80000, Argentina.
Extracellular vesicles (EVs) are natural nanocarriers with therapeutic potential, offering advantages like biocompatibility and drug delivery. Challenges in characterization and cost hinder clinical use, but advancements offer future therapeutic pathways.
Area of Science:
- Biotechnology
- Nanomedicine
- Cell Biology
Background:
- Extracellular vesicles (EVs) are nano-sized, cell-derived systems found in body fluids, carrying biomolecules from their source cells.
- EVs are implicated in physiological processes and diseases like cancer and neurodegenerative disorders.
- Their structure allows them to act as natural drug carriers, similar to synthetic liposomes.
Purpose of the Study:
- To review the classification, physiological roles, and therapeutic applications of EVs.
- To discuss current methods for EV isolation, purification, and functionalization for drug delivery.
- To explore novel pathways and future perspectives for EV-based therapeutics.
Main Methods:
- Literature review on EV classification, isolation, purification, and therapeutic applications.
- Analysis of EV-mediated drug delivery strategies and functionalization techniques.
- Discussion of challenges and future directions in clinical applications.
Main Results:
- EVs possess inherent biocompatibility, blood-brain barrier penetration, and gene delivery capabilities, surpassing synthetic nanocarriers.
- Current EV isolation and characterization methods face standardization challenges.
- EV functionalization offers versatile strategies for targeted drug delivery.
Conclusions:
- EVs represent a promising platform for advanced drug delivery systems in various medical fields.
- Addressing challenges in standardization and cost is crucial for widespread clinical translation.
- Further research into EV-based therapeutics will pave the way for novel treatments.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

